36.60

1.30% 0.47

After Hours: 36.78 0.18 +0.49%

Assembly Biosciences Inc (ASMB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Assembly Biosciences Inc stock is traded at $36.60, with a volume of 156.45K. It is up +1.30% in the last 24 hours and up +38.43% over the past month. Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Previous Close:

$36.13

Open:

$35.68

24h Volume:

156.45K

Relative Volume:

0.66

Market Cap:

$745.20M

Revenue:

$71.10M

Net Income/Loss:

$-6.38M

P/E Ratio:

-30.48

EPS:

-1.2009

Net Cash Flow:

$-39.84M

1W Performance:

+7.43%

1M Performance:

+38.43%

6M Performance:

+22.86%

1Y Performance:

+57.01%

1-Day Range:

$35.48

$36.77

1-Week Range:

$32.92

$37.01

52-Week Range:

$20.23

$39.70

Assembly Biosciences Inc Stock (ASMB) Company Profile

Name

Assembly Biosciences Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(833) 409-4583

Address

TWO TOWER PLACE, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2026-08-19

Latest SEC Filings

ASMB's Discussions on Twitter

Compare ASMB vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ASMB Assembly Biosciences Inc	36.60	682.69M	71.10M	-6.38M	-39.84M	-1.2009
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Initiated	Citizens JMP	Mkt Outperform
Aug-18-25	Resumed	H.C. Wainwright	Buy
Mar-25-25	Initiated	Guggenheim	Buy
Sep-20-24	Upgrade	Jefferies	Hold → Buy
Sep-13-21	Initiated	H.C. Wainwright	Neutral
Sep-02-21	Downgrade	William Blair	Outperform → Mkt Perform
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-06-20	Downgrade	Jefferies	Buy → Hold
Oct-19-20	Initiated	Truist	Buy
Oct-16-19	Initiated	Mizuho	Buy
Nov-19-18	Initiated	Leerink Partners	Outperform
Oct-08-18	Upgrade	B. Riley FBR	Neutral → Buy
Aug-08-18	Initiated	Robert W. Baird	Outperform
Apr-13-18	Downgrade	Chardan Capital Markets	Buy → Neutral
Jan-05-18	Initiated	B. Riley FBR, Inc.	Neutral
Nov-08-17	Initiated	Jefferies	Buy
May-30-17	Initiated	Chardan Capital Markets	Buy

View All

Assembly Biosciences Inc Stock (ASMB) Latest News

09:55 AM

Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High? - Yahoo Finance

09:55 AM

Sep 04, 2026

Should You Buy Assembly Biosciences (ASMB) After Golden Cross? - Yahoo Finance

Sep 04, 2026

How Assembly Biosciences Inc. (ASMB) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Sep 04, 2026

Sep 03, 2026

Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going - Yahoo Finance

Sep 03, 2026

Sep 02, 2026

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail

Sep 02, 2026

Sep 01, 2026

UBS initiates Assembly Biosciences stock with buy rating on antiviral platform - Investing.com Nigeria

Sep 01, 2026

Aug 31, 2026

Mizuho lowers Assembly Biosciences stock price target to $45 - Investing.com

Aug 31, 2026

Aug 28, 2026